TRANSIENT BENEFITS BUT LACK OF PROTECTION BY SODIUM PYRUVATE AFTER 2-HOUR MIDDLE CEREBRAL ARTERY OCCLUSION IN THE RAT.
El splicing alternativo de H-Ras en mamíferos une varios factores de splicing a procesos cancerígenos.
Tissue plasminogen activator induces pancreas cancer cell proliferation by a non-catalytic mechanism that requires ERK1/2 activation through Epidermal Growth Factor Receptor and Annexin A2
''CCAAT/ENHANCER BINDING PROTEIN ALPHA IS DOWNREGULATED BY TOLL-LIKE RECEPTOR AGONISTS IN MICROGLIAL CELLS.''
"UPREGULATION OF CCAAT/ENHANCER BINDING PROTEIN BETA IN ACTIVATED ASTROCYTES AND MICROGLIA."
''DISTRIBUTION OF CLOSTRIDIUM PERFRINGENS EPSILON TOXIN IN THE BRAINS OF ACUTELY INTOXICATED MICE AND ITS EFFECT PON GLIAL CELLS.''
Trimethylguanosine nucleoside inhibits cross-linking between Snurportin 1 and m3G-capped U1 snRNP
Tissue plasminogen activator mediates amyloid induced neurotoxicity via sustained Erk1/2 activation.
The tissue plasminogen activator system in murine exocrine pancreas cancer:selective expression in ductal tumors and contribution to cancer progression.
New insights into the tPA-Annexin A2 interaction: is Annexin A2 Cys8 the sole requirement for this association?
Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein which trafficks to cytoplasm and nucleus.
HnRNP A1 and SR proteins regulate the alternative splicing of proto-oncogen c-H-ras, balancing the relative abundance of two alternative H-Ras proteins, p19 and p21.
Study of the 2719 mutant of the c-H-ras oncogen in a bi-intronic alternative splicing system.
Modulation in vitro of H-ras oncogene expresión by trans-splicing
Post-transcriptional regulation of rat carnitine octanoyltransferase.
Localization of an exonic splicing enhancer responsible for mammalian natural trans-splicing
Alternative splicing of c-H-ras, a system to study different aspects of the splicing mechanism.
Processing of carnitine octanoyltransferase pre-mRNAs by cis and trans-splicing.
